Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Average EV/EBITDA Ratio

EV/EBITDA Ratio

The today ev/ebitda ratio is 14.46x as of Saturday, June 27, 2026, shown against its trailing averages.

DGX EV/EBITDA Ratio

DGX Average EV/EBITDA Ratio

DGX EV/EBITDA Ratio Averages

EV/EBITDA RATIO TODAY

14.46x

EV/EBITDA RATIO TTM

13.22x

EV/EBITDA RATIO 3Y

12.93x

EV/EBITDA RATIO 5Y

11.16x

EV/EBITDA RATIO 10Y

11.44x

EV/EBITDA RATIO 15Y

10.48x

EV/EBITDA RATIO 20Y

10.11x

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis